Abstract
Primary cutaneous CD4+ small /medium T-cell lymphoproliferative disorder (PC-SMTLD) has recently been considered as a distinct clinicopathological entity. Because of a considerable degree of overlap with pseudolymphoma, diagnosis of PC-SMTLD is often challenging. The methylation of DNA at position 5 of cytosine, and the subsequent reduction in intracellular 5-hydroxymethylcytosine (5-hmC) levels, is a key epigenetic event in several cancers, including systemic lymphomas. However, this epigenetic marker has never been studied in cutaneous lymphomas.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.